A phase III, observer-blind, randomized, controlled, multicenter study to evaluate safety, tolerability, and immunogenicity of two trivalent subunit inactivated influenza vaccines in healthy children aged 3 to 8 years, in healthy children/adolescents aged 9 to 17 years and in healthy adults aged 18 to 64 years

Trial Profile

A phase III, observer-blind, randomized, controlled, multicenter study to evaluate safety, tolerability, and immunogenicity of two trivalent subunit inactivated influenza vaccines in healthy children aged 3 to 8 years, in healthy children/adolescents aged 9 to 17 years and in healthy adults aged 18 to 64 years

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 22 Apr 2008 This trial was completed in April 2008.
    • 22 Apr 2008 Status changed from recruiting to completed.
    • 09 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top